FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W959729077> ?p ?o ?g. }

• W959729077 endingPage "412" @default.
• W959729077 startingPage "407" @default.
• W959729077 abstract "To investigate whether patients with germline BRCA1/2 mutations who received neoadjuvant chemotherapy (NAC) for advanced-stage Müllerian cancer (MC) have an improved outcome compared to patients who did not undergo genetic testing.Three hundred and two patients who received NAC for stage III-IV MC were identified from a multi-institutional study involving Cleveland Clinic and Brigham and Women's Hospital for 2000-2014 and 2010-2014 respectively. Patients were divided into 3 cohorts: patients with germline BRCA1/2 mutations (BRCA_mut+; N=30), patients with no genetic testing (BRCA_mut_unk; N=166) and patients with negative genetic testing (BRCA_mut-, N=106).There were no differences in the clinical characteristics and rates of complete cytoreduction and bowel resection between the three groups. BRCA_mut+ had longer PFS compared to BRCA_mut_unk and BRCA_mut- (19.1 vs. 15.1 vs. 15.7months respectively. However, this difference was not statistically significant (p=0.48). Patients with BRCA2 mutation had non-significant trend toward longer PFS compared to patients with unknown BRCA or BRCA1 mutation (20.2 vs. 15.1 vs. 14.8months respectively, p=0.58). BRCA_mut+ and BRCA_mut- had longer overall survivals (OS) compared to BRCA_mut_unk patients (50.5 vs. 54.1 vs. 36.5months respectively, p=0.009). In multivariable analyses, controlling for age, stage and complete cytoreduction, BRCA_mut_unk was associated with worse PFS (HR 1.44, 95% CI 1.01-2.05, p=0.045) and OS (HR 2.67, 95% CI 1.33-5.36, p=0.006).Patients with germline BRCA mutations had improved outcomes with NAC compared to patients with unknown BRCA status. These outcomes were more favorable compared to the outcome of NAC in prior studies." @default.
• W959729077 created "2016-06-24" @default.
• W959729077 creator A5005911289 @default.
• W959729077 creator A5047074488 @default.
• W959729077 creator A5047313142 @default.
• W959729077 creator A5049857815 @default.
• W959729077 creator A5053185829 @default.
• W959729077 creator A5053431449 @default.
• W959729077 creator A5079720679 @default.
• W959729077 creator A5089158382 @default.
• W959729077 creator A5089239939 @default.
• W959729077 date "2015-12-01" @default.
• W959729077 modified "2023-10-18" @default.
• W959729077 title "Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer" @default.
• W959729077 cites W1894955529 @default.
• W959729077 cites W1941585236 @default.
• W959729077 cites W1998606142 @default.
• W959729077 cites W2000197817 @default.
• W959729077 cites W2073406089 @default.
• W959729077 cites W2093349285 @default.
• W959729077 cites W2097265582 @default.
• W959729077 cites W2106157865 @default.
• W959729077 cites W2106767659 @default.
• W959729077 cites W2135525536 @default.
• W959729077 cites W2147539392 @default.
• W959729077 cites W2154175915 @default.
• W959729077 cites W2154885792 @default.
• W959729077 cites W2169983032 @default.
• W959729077 cites W2170552969 @default.
• W959729077 cites W2172163625 @default.
• W959729077 cites W4233920089 @default.
• W959729077 doi "https://doi.org/10.1016/j.ygyno.2015.07.101" @default.
• W959729077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26210778" @default.
• W959729077 hasPublicationYear "2015" @default.
• W959729077 type Work @default.
• W959729077 sameAs 959729077 @default.
• W959729077 citedByCount "14" @default.
• W959729077 countsByYear W9597290772016 @default.
• W959729077 countsByYear W9597290772017 @default.
• W959729077 countsByYear W9597290772018 @default.
• W959729077 countsByYear W9597290772019 @default.
• W959729077 countsByYear W9597290772020 @default.
• W959729077 countsByYear W9597290772021 @default.
• W959729077 countsByYear W9597290772022 @default.
• W959729077 countsByYear W9597290772023 @default.
• W959729077 crossrefType "journal-article" @default.
• W959729077 hasAuthorship W959729077A5005911289 @default.
• W959729077 hasAuthorship W959729077A5047074488 @default.
• W959729077 hasAuthorship W959729077A5047313142 @default.
• W959729077 hasAuthorship W959729077A5049857815 @default.
• W959729077 hasAuthorship W959729077A5053185829 @default.
• W959729077 hasAuthorship W959729077A5053431449 @default.
• W959729077 hasAuthorship W959729077A5079720679 @default.
• W959729077 hasAuthorship W959729077A5089158382 @default.
• W959729077 hasAuthorship W959729077A5089239939 @default.
• W959729077 hasConcept C104317684 @default.
• W959729077 hasConcept C109825262 @default.
• W959729077 hasConcept C121608353 @default.
• W959729077 hasConcept C126322002 @default.
• W959729077 hasConcept C143998085 @default.
• W959729077 hasConcept C146357865 @default.
• W959729077 hasConcept C151730666 @default.
• W959729077 hasConcept C2776694085 @default.
• W959729077 hasConcept C2780194787 @default.
• W959729077 hasConcept C2780673598 @default.
• W959729077 hasConcept C29456083 @default.
• W959729077 hasConcept C530470458 @default.
• W959729077 hasConcept C54355233 @default.
• W959729077 hasConcept C71924100 @default.
• W959729077 hasConcept C86803240 @default.
• W959729077 hasConcept C90924648 @default.
• W959729077 hasConceptScore W959729077C104317684 @default.
• W959729077 hasConceptScore W959729077C109825262 @default.
• W959729077 hasConceptScore W959729077C121608353 @default.
• W959729077 hasConceptScore W959729077C126322002 @default.
• W959729077 hasConceptScore W959729077C143998085 @default.
• W959729077 hasConceptScore W959729077C146357865 @default.
• W959729077 hasConceptScore W959729077C151730666 @default.
• W959729077 hasConceptScore W959729077C2776694085 @default.
• W959729077 hasConceptScore W959729077C2780194787 @default.
• W959729077 hasConceptScore W959729077C2780673598 @default.
• W959729077 hasConceptScore W959729077C29456083 @default.
• W959729077 hasConceptScore W959729077C530470458 @default.
• W959729077 hasConceptScore W959729077C54355233 @default.
• W959729077 hasConceptScore W959729077C71924100 @default.
• W959729077 hasConceptScore W959729077C86803240 @default.
• W959729077 hasConceptScore W959729077C90924648 @default.
• W959729077 hasIssue "3" @default.
• W959729077 hasLocation W9597290771 @default.
• W959729077 hasLocation W9597290772 @default.
• W959729077 hasOpenAccess W959729077 @default.
• W959729077 hasPrimaryLocation W9597290771 @default.
• W959729077 hasRelatedWork W2012143939 @default.
• W959729077 hasRelatedWork W2348231456 @default.
• W959729077 hasRelatedWork W2354050160 @default.
• W959729077 hasRelatedWork W2367105124 @default.
• W959729077 hasRelatedWork W2368979736 @default.
• W959729077 hasRelatedWork W2369039771 @default.

• next